Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Aug 5, 2015 landry robert e Officer Sell 4,000 591.78 - 593.38
Aug 5, 2015 terifay robert j Officer Disposition (Non Open Market) 15,813 588.64
Aug 5, 2015 van plew daniel p Officer Disposition (Non Open Market) 4,672 588.64
Nov 18, 2015 vagelos p roy Officer Sell 17,240 586.73 - 588.40
Aug 4, 2015 goldstein joseph l Director Automatic Sell 2,000 586.00
Aug 5, 2015 mccorkle douglas s Officer Sell 5,000 585.51 - 586.00
Aug 6, 2015 terifay robert j Officer Sell 13,423 585.22 - 593.66
Aug 5, 2015 tessier-lavigne marc Director Sell 5,000 584.07 - 595.44
Aug 6, 2015 gilman alfred g Director Sell 5,000 582.15 - 593.00
Aug 6, 2015 van plew daniel p Officer Sell 4,028 582.12 - 586.24
Nov 3, 2015 vagelos p roy Officer Automatic Sell 3,985 580.23
Nov 2, 2015 vagelos p roy Officer Automatic Sell 13,257 580.18
Nov 18, 2015 sing george l Director Sell 3,000 580.00
Nov 18, 2015 sing george l Director Sell 500 580.00
Aug 13, 2015 powchik peter Officer Disposition (Non Open Market) 36,876 579.35
Aug 11, 2015 poon christine a Director Disposition (Non Open Market) 223 574.57
Aug 14, 2015 powchik peter Officer Sell 23,485 569.63 - 578.63
Nov 5, 2015 stahl neil Officer Disposition (Non Open Market) 57,899 567.63
Aug 12, 2015 poon christine a Director Sell 112 564.16 - 564.17
Nov 6, 2015 stahl neil Officer Sell 20,000 562.37 - 564.19
Showing 1-20 of 1036 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)